22 February 2002
Tumor markers in metastatic disease from cancer of unknown primary origin.
Ivan Popov, Marijana Milović, Svietislav JelićMed Sci Monit 2002; 8(2): MT25-30 :: ID: 420926
Abstract
BACKGROUND: About 5-10% of cancer patients suffer from cancer of unknownprimary (CUP). Sophisticated diagnostic techniques have not improved diagnostic efficacy for these patients.The aim of our analysis was to evaluate serum levels of four tumor markers and to relate them to thehistology, number, and sites of metastases, the response to chemotherapy, and survival. MATERIAL/METHODS:Blood samples from 46 patients with CUP were assayed for CEA, CA 19-9, CA 15-3 and CA 125. Specific IMxtumor marker assays (Abbott) were used to measure tumor marker quantities. RESULTS: No significant differenceswere detected between the mean levels of all markers for the two histological types (adenocarcinoma vs.undifferentiated carcinoma). The comparison of tumor marker values in patients with one metastatic locationto those with two or more showed no significant differences. We found no differences in marker valuesbetween patients with disease sites in the thorax vs. those with abdominal metastases. The comparisonof marker negative, CEA positive and non-CEA positive patients failed to reveal significant differencesin response rate. The comparison of CEA positive and marker negative patients showed significant differencesin survival (log-rank, p=0.02). CONCLUSIONS: Our results suggest that patients with CUP have a nonspecificoverexpression of serum tumor markers and that routine use of these markers does not offer diagnosticassistance. Nevertheless, the pattern of expression of some biological markers, such as CEA, could haveprognostic significance for survival.
Keywords: Neoplasms, Unknown Primary, Tumor Markers, Biological
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
06 Mar 2024 : Clinical Research
Prevalence and Variation of Medical Comorbidities in Oral Surgery Patients: A Retrospective Study at Jazan ...Med Sci Monit In Press; DOI: 10.12659/MSM.943884
08 Mar 2024 : Clinical Research
Evaluation of Foot Structure in Preschool Children Based on Body MassMed Sci Monit In Press; DOI: 10.12659/MSM.943765
15 Apr 2024 : Laboratory Research
The Role of Copper-Induced M2 Macrophage Polarization in Protecting Cartilage Matrix in OsteoarthritisMed Sci Monit In Press; DOI: 10.12659/MSM.943738
07 Mar 2024 : Clinical Research
Knowledge of and Attitudes Toward Clinical Trials: A Questionnaire-Based Study of 179 Male Third- and Fourt...Med Sci Monit In Press; DOI: 10.12659/MSM.943468
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952